Laurus Labs Ltd receives EIR from USFDA for Unit 5, Parawada, Vizag

Further to the Pre-Approval Inspection (PAI) conducted by the United States Food & Drug Administration (USFDA) at Laurus Labs Ltd's manufacturing facility at Unit-5, Parawada, Visakhapatnam, Andhra Pradesh from 24th October 2022 to 28th October 2022, the Company has received the Establishment Inspection Report (EIR) from USFDA.

Shares of Laurus Labs Limited was last trading in BSE at Rs. 351.50 as compared to the previous close of Rs. 354.65. The total number of shares traded during the day was 61148 in over 2792 trades.

The stock hit an intraday high of Rs. 354.00 and intraday low of 349.35. The net turnover during the day was Rs. 21449891.00.

Source : Equity Bulls

Keywords

LaurusLabs INE947Q01028 Pharmaceuticals EIR USFDA Manufacturing Facility Parawada Visakhapatnam